JP2013540791A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013540791A5 JP2013540791A5 JP2013535408A JP2013535408A JP2013540791A5 JP 2013540791 A5 JP2013540791 A5 JP 2013540791A5 JP 2013535408 A JP2013535408 A JP 2013535408A JP 2013535408 A JP2013535408 A JP 2013535408A JP 2013540791 A5 JP2013540791 A5 JP 2013540791A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- vegf
- inhibitor
- methyl
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40721810P | 2010-10-27 | 2010-10-27 | |
| US61/407,218 | 2010-10-27 | ||
| PCT/EP2011/068682 WO2012055884A1 (en) | 2010-10-27 | 2011-10-25 | Dosing regimes for the treatment of ocular vascular disease |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013540791A JP2013540791A (ja) | 2013-11-07 |
| JP2013540791A5 true JP2013540791A5 (https=) | 2014-12-04 |
| JP5934229B2 JP5934229B2 (ja) | 2016-06-15 |
Family
ID=44913251
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013535408A Expired - Fee Related JP5934229B2 (ja) | 2010-10-27 | 2011-10-25 | 眼血管疾患の処置のための投与計画 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20130197016A1 (https=) |
| EP (1) | EP2632458B1 (https=) |
| JP (1) | JP5934229B2 (https=) |
| KR (1) | KR20140008303A (https=) |
| CN (1) | CN103167873A (https=) |
| AU (1) | AU2011322597B2 (https=) |
| BR (1) | BR112013009701A2 (https=) |
| CA (1) | CA2814439A1 (https=) |
| EA (1) | EA022873B1 (https=) |
| ES (1) | ES2547145T3 (https=) |
| MX (1) | MX2013004782A (https=) |
| WO (1) | WO2012055884A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9395468B2 (en) | 2012-08-27 | 2016-07-19 | Ocular Dynamics, Llc | Contact lens with a hydrophilic layer |
| JP6669499B2 (ja) * | 2013-02-15 | 2020-03-18 | カラ ファーマシューティカルズ インコーポレイテッド | 治療用化合物 |
| US10174006B2 (en) * | 2013-06-06 | 2019-01-08 | Novartis Ag | Topical aqueous ophthalmic compositions containing a 1H-indole-1-carboxamide derivative and use thereof for treatment of ophthalmic disease |
| CN105917270A (zh) | 2013-11-15 | 2016-08-31 | 视觉力学有限责任公司 | 具有亲水层的接触透镜 |
| JPWO2015147204A1 (ja) * | 2014-03-27 | 2017-04-13 | 国立大学法人京都大学 | 血管新生増殖因子を阻害する医薬組成物 |
| JP6774947B2 (ja) | 2014-12-09 | 2020-10-28 | タンジブル サイエンス インコーポレイテッド | 生体適合性層を有する医療デバイスコーティング |
| CN118718181A (zh) | 2019-06-05 | 2024-10-01 | 里珍纳龙药品有限公司 | 用于精确剂量递送的装置及方法 |
| WO2021067823A2 (en) * | 2019-10-05 | 2021-04-08 | The Schepens Eye Research Institute, Inc. | A new treatment for meibomian gland dysfunction |
| USD1120314S1 (en) | 2022-11-30 | 2026-03-24 | Regeneron Pharmaceuticals, Inc. | Dose delivery device |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1652847B1 (en) | 2001-04-27 | 2008-05-28 | Kirin Pharma Kabushiki Kaisha | Quinoline and quinazoline derivatives for the treatment of tumors |
| PE20060664A1 (es) | 2004-09-15 | 2006-08-04 | Novartis Ag | Amidas biciclicas como inhibidores de cinasa |
| PL1954281T3 (pl) | 2005-11-29 | 2011-07-29 | Novartis Ag | Sposób leczenia raka |
| CA2666709A1 (en) * | 2006-11-10 | 2008-05-29 | Genentech, Inc. | Method for treating age-related macular degeneration |
| JO3265B1 (ar) | 2008-12-09 | 2018-09-16 | Novartis Ag | مثبطات بيريديلوكسى اندولات vegf-r2 واستخدامها لعلاج المرض |
-
2011
- 2011-10-25 BR BR112013009701A patent/BR112013009701A2/pt not_active IP Right Cessation
- 2011-10-25 JP JP2013535408A patent/JP5934229B2/ja not_active Expired - Fee Related
- 2011-10-25 AU AU2011322597A patent/AU2011322597B2/en not_active Ceased
- 2011-10-25 CA CA2814439A patent/CA2814439A1/en not_active Abandoned
- 2011-10-25 EP EP11779606.0A patent/EP2632458B1/en not_active Not-in-force
- 2011-10-25 CN CN2011800496321A patent/CN103167873A/zh active Pending
- 2011-10-25 US US13/878,678 patent/US20130197016A1/en not_active Abandoned
- 2011-10-25 ES ES11779606.0T patent/ES2547145T3/es active Active
- 2011-10-25 WO PCT/EP2011/068682 patent/WO2012055884A1/en not_active Ceased
- 2011-10-25 EA EA201390618A patent/EA022873B1/ru not_active IP Right Cessation
- 2011-10-25 KR KR1020137010744A patent/KR20140008303A/ko not_active Withdrawn
- 2011-10-25 MX MX2013004782A patent/MX2013004782A/es not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013540791A5 (https=) | ||
| CN103458690B (zh) | 治疗肺动脉高压的组合物和方法 | |
| CN105246889B (zh) | 氟化整联蛋白拮抗剂 | |
| JP4643760B2 (ja) | Ｄｐｐ−ｉｖ阻害薬と他の糖尿病治療薬との併用又は組み合せからなる医薬 | |
| HRP20171829T1 (hr) | 2-piridil supstituirani imidazoli kao terapijski inhibitori alk5 i/ili alk4 | |
| ES2370751T3 (es) | Agente profiláctico o terapéutico para la degeneración macular asociada a la edad. | |
| RU2016121150A (ru) | Терапевтическое средство против заболеваний, связанных с гибелью клеток эндотелия роговицы, обусловленной состоянием эндоплазматического ретикулума | |
| US20130171103A1 (en) | Methods for treating viral conditions | |
| JP5934229B2 (ja) | 眼血管疾患の処置のための投与計画 | |
| RU2017112930A (ru) | Офтальмологические составы для доставки лекарств и защиты переднего отдела глаза | |
| AU2024202380A1 (en) | Methods of preventing or treating ophthalmic diseases | |
| JP2019524710A (ja) | Ｓｇｃ刺激剤の固体形態 | |
| ES2694375T3 (es) | Composiciones para el tratamiento de la hipertensión y/o de la fibrosis | |
| TW200815416A (en) | Compositions and methods for treating, reducing, ameliorating, or alleviating posterior-segment ophthalmic diseases | |
| WO2008020032A8 (en) | Use of 2,5-dihydroxybenzene derivatives for the treatment of ocular diseases | |
| US20150306084A1 (en) | Adenosine a1 agonists for the treatment of glaucoma and ocular hypertension | |
| JP2017527600A5 (https=) | ||
| EP3664780A1 (en) | Pharmaceutical compositions | |
| RU2019114205A (ru) | Способы лечения глазного заболевания с применением ингибиторов csf-1r | |
| WO2007075720A3 (en) | Topical mecamylamine formulations for ocular administration and uses thereof | |
| JPWO2014157727A1 (ja) | 眼疾患治療剤 | |
| KR20140135215A (ko) | 특정한 종양의 치료를 위한 (rs)-s-시클로프로필-s-(4-｛[4-｛[(1r, 2r)-2-히드록시-1-메틸프로필]옥시｝-5-(트리플루오로메틸)피리미딘-2-일]아미노｝페닐)술폭시미드의 용도 | |
| US20210121447A1 (en) | The Use of Non-Steroidal Mineralocorticoid Receptor Antagonists Alone or in Combination for the Treatment of Muscular or Neuromuscular Diseases | |
| HK1188138B (en) | Adenosine a1 agonists for the treatment of glaucoma and ocular hypertension | |
| TH64147A (th) | การใช้ประโยชน์ทางเภสัชกรรมของสารยับยั้ง cox-2 ในความผิดปกติของดวงตาที่สื่อโดยการเจริญเติบโตของเส้นโลหิต |